Targeted photodynamic therapy technique of Janus nanoparticles on breast cancer
Source abstract
Abstract
Spherical gold/polyacrylic acid (Au/PAA) polymer–inorganic Janus nanoparticles (JNPs) with simultaneous therapeutic and targeting functions were fabricated. The obtained Au/PAA JNPs were further selectively functionalized with folic acid (FA) and thiol PEG amine (SH-PEG-NH2) on Au sides to provide superior biocompatibility and active targeting, while the other PAA sides were loaded with 5-aminolevulinic acid (5-ALA) to serve as a photosensitizer (PS) for photodynamic therapeutic (PDT) effects on MCF-7 cancer cells. The PS loading of 5-ALA was found to be 83% with an average hydrodynamic size and z-potential of 146 ± 0.8 nm and −6.40 mV respectively for FA-Au/PAA-ALA JNPs. The in vitro PDT study of the JNPs on MCF-7 breast cancer cells under 636 nm laser irradiation indicated the cell viability of 24.7% ± 0.5 for FA-Au/PAA-ALA JNPs at the IC50 value of 0.125 mM. In this regard, the actively targeted FA-Au/PAA-ALA JNPs treatment holds great potential for tumour therapy with high cancer cell-killing efficacy.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Laser Research Centre, Faculty of Health Sciences, University of Johannesburg, Doornfontein, South Africa
Department of Surgery and Cancer, Imperial College London, London, United Kingdom
Funding
South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation of South Africa
References (24)
Show source-provided references
1. 10.1039/b718131k10.1039/b718131k ↗
2. 10.1039/c6an00325g10.1039/c6an00325g ↗
3. 10.1039/c4cs00345d10.1039/c4cs00345d ↗
4. 10.1021/ja102489q10.1021/ja102489q ↗
5. 10.1002/adma.20130137610.1002/adma.201301376 ↗
6. 10.1021/jacs.6b0563310.1021/jacs.6b05633 ↗
7. 10.1039/c7sc03521g10.1039/c7sc03521g ↗
8. 10.1039/c8bm01523f10.1039/c8bm01523f ↗
9. 10.1002/advs.20180027110.1002/advs.201800271 ↗
10. 10.1021/cr400532z10.1021/cr400532z ↗
11. 10.1002/smll.20120173510.1002/smll.201201735 ↗
12. 10.1039/c3nr33695f10.1039/c3nr33695f ↗
13. 10.1016/0021-9797(70)90073-110.1016/0021-9797(70)90073-1 ↗
14. 10.3390/pharmaceutics1309137510.3390/pharmaceutics13091375 ↗
15. 10.1021/ja102591z10.1021/ja102591z ↗
16. 10.1002/smll.20090038910.1002/smll.200900389 ↗
17. 10.1016/j.colsurfb.2010.03.04010.1016/j.colsurfb.2010.03.040 ↗
18. 10.1021/acsomega.8b0041910.1021/acsomega.8b00419 ↗
19. 10.1002/chem.20170349810.1002/chem.201703498 ↗
20. 10.1021/jp510924n10.1021/jp510924n ↗
21. 10.1016/0304-3991(84)90144-X10.1016/0304-3991(84)90144-X ↗
22. 10.1016/j.powtec.2012.11.00310.1016/j.powtec.2012.11.003 ↗
23. 10.1016/s1386-1425(03)00011-810.1016/s1386-1425(03)00011-8 ↗
24. 10.1021/acsnano.5b0002110.1021/acsnano.5b00021 ↗